Oncology Venture ApS has a total of 26 patent applications. It decreased the IP activity by 33.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and computer technology are QINGDAO YANGSHEN BIOLOGICAL MEDICINE CO LTD, COURTAGEN LIFE SCIENCES INC and SUREGENE LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Australia | 4 | |
#3 | Canada | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | China | 3 | |
#6 | Hong Kong | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Computer technology | |
#4 | Environmental technology | |
#5 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Knudsen Steen | 25 |
#2 | Jensen Peter Buhl | 2 |
#3 | Steen Knudsen | 1 |
Publication | Filing date | Title |
---|---|---|
US10835531B1 | Methods for predicting drug responsiveness in cancer patients | |
WO2019219759A1 | Methods for predicting drug responsiveness in cancer patients | |
AU2018202878A1 | Methods for predicting drug responsiveness in cancer patients | |
AU2017258901A1 | Methods for predicting drug responsiveness in cancer patients | |
US9725769B1 | Methods for predicting drug responsiveness in cancer patients | |
US2018087113A1 | Methods for predicting drug responsiveness in cancer patients |